Prostate CancereMindExCareNCT07735273
eMindExCare for Prostate Cancer Patients Undergoing Active Treatment
A study testing eMindExCare and Enhanced Health Education in people with Prostate Cancer and Sleep Disturbance, run by The University of Hong Kong at 1 site in Hong Kong.
Trial summary
This feasibility randomized controlled trial will assess the acceptability, feasibility, and preliminary effects of an integrated mindfulness and exercise eHealth intervention, eMindExCare, among prostate cancer patients undergoing active treatment in Hong Kong. Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Prostate Cancer, Sleep Disturbance, Fatigue
- What is being tested?
- eMindExCare and Enhanced Health Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Oct 2026to 30 Sep 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosed with prostate cancer, stage I, II, or III.
- Aged older than 18 years.
- Undergoing active treatment, including chemotherapy, radiotherapy, or hormone therapy, at Prince of Wales Hospital.
- Able to communicate and read Chinese.
- Has access to the Internet and a computer or tablet.
- Demonstrates clinically impaired sleep quality or insufficient physical activity as measured by ActiGraph. Clinically impaired sleep quality may include study-defined sleep disturbance criteria such as total sleep time less than 6.5 hours, sleep onset latency greater than 30 minutes, awakenings lasting greater than 5 minutes, or wake after sleep onset greater than 30 minutes.
Who cannot join
- Diagnosed with more than one primary cancer.
- Has metastatic disease.
- Has participated in a mindfulness programme.
- Is sufficiently physically active at the time of recruitment.
- Has a mental condition, World Health Organization/Eastern Cooperative Oncology Group performance status greater than 2, a physical disability that prevents participation in the intervention, or any other health problem that rules out regular physical activity as determined by the treating physician.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site
Prince of Wales Hospital, Urology Division
Hong Kong
Chi Fai NG, Professor, +85235052625, ngcf@surgery.cuhk.edu.hk
About this study
Official title: Effects of Integrated Mindfulness and Exercise eHealth Intervention (eMindExCare) on Sleep, Fatigue, and Physical Activity Among Prostate Cancer Patients Undergoing Active Treatment: A Feasibility Trial
This feasibility randomized controlled trial will assess the acceptability, feasibility, and preliminary effects of an integrated mindfulness and exercise eHealth intervention, eMindExCare, among prostate cancer patients undergoing active treatment in Hong Kong. Participants will be randomized in a 1:1 ratio to either an 8-week eMindExCare intervention or an enhanced health education attention-control programme. eMindExCare integrates culturally adapted Cantonese mindfulness practices with home-based aerobic and resistance exercise delivered through Zoom, supported by home practice, exercise logs, and weekly reminders. The enhanced health education control programme will match the intervention group in contact time and engagement but will not include progressive aerobic training, resistance-band prescription, stationary bike provision, or a structured mindfulness curriculum. Feasibility and acceptability outcomes will include eligibility, consent, randomization, attendance, retention, questionnaire completion, missing data, and adverse events. Preliminary outcomes will include sleep quality, fatigue, pain, physical activity, mindfulness, motivation for exercise, and quality of life assessed at baseline, immediately post-intervention at week 8, and 3 months post-intervention.
Read the detailed description
Prostate cancer patients undergoing active treatment commonly experience interrelated symptoms, including sleep disturbance, fatigue, pain, and reduced physical activity. These symptoms may negatively affect physical functioning, psychological well-being, and quality of life. Mindfulness-based approaches may improve sleep quality and coping, while aerobic and resistance exercise may reduce fatigue, pain, and physical inactivity. However, these approaches are often delivered separately, and there is limited evidence on integrated mindfulness and exercise eHealth interventions for men with prostate cancer.
The eMindExCare programme was developed based on mindfulness-based cancer recovery principles, exercise and cancer guidelines, previous literature, and the study team's systematic reviews of exercise and mindfulness interventions. The programme is informed by the mindful coping model and self-determination theory. It aims to promote adaptive coping, present-moment awareness, intrinsic motivation for health behaviour change, and competence in practicing mindfulness and physical activity.
eMindExCare will be delivered online through Zoom over 8 consecutive weeks. Each weekly session will last approximately 60 minutes and will include a brief introduction, mindfulness practice, aerobic/resistance exercise, and sharing or discussion. The first session will be delivered in small groups of three to four participants to introduce the programme and explain how mindfulness and exercise may help manage cancer-related symptoms. The remaining sessions will be delivered individually, with follow-up and reminders through WhatsApp or WeChat. Participants will be encouraged to complete home-based practice at least three times per week for approximately 30 minutes. Intervention participants will be provided with a stationary bike, resistance band, mindfulness mat and zafu set, and mindfulness and exercise videos to support home practice.
Exercise will be delivered at a low-to-moderate intensity, approximately Borg Rating of Perceived Exertion 11-13, or a level at which participants can talk but not sing. Exercise intensity will be gradually progressed. Aerobic exercise will include stationary cycling or walking, and resistance training will use elastic bands to work major muscle groups. Participants will record daily practice and homework in a standardized exercise log.
Participants in the control group will receive an enhanced health education attention-control programme delivered via Zoom. The programme will include cancer self-management education, basic breath-awareness or relaxation, and light non-progressive physical activity guidance such as posture, gentle stretching, walking tips, and sit-to-stand activities. It will match the intervention group in contact time and engagement but will not include the structured eMindExCare mindfulness curriculum or progressive aerobic/resistance exercise prescription.
The primary objective is to assess the feasibility and acceptability of implementing eMindExCare in prostate cancer patients undergoing active treatment in the Hong Kong context. The secondary objective is to estimate preliminary effects on sleep quality, fatigue, pain, physical activity, mindfulness, exercise motivation, and quality of life. A process evaluation using semi-structured interviews will explore participants' experiences, perceptions, and feedback to refine the programme before a larger randomized controlled trial.
- Conditions
- Prostate Cancer, Sleep Disturbance, Fatigue, Physical Inactivity, Pain
- Being tested
- eMindExCare, Enhanced Health Education
- Keywords
- Prostate Cancer, prostate neoplasms, eMindExCare, mindfulness, exercise, physical activity, eHealth, sleep quality, sleep disturbance, fatigue, pain, quality of life, feasibility trial, pilot randomized controlled trial, Hong Kong
- Medical subject headings
- Prostatic Neoplasms, Parasomnias, Fatigue, Sedentary Behavior, Pain, Motor Activity, Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
eMindExCareBehavioural
An integrated mindfulness and exercise eHealth intervention for prostate cancer patients undergoing active treatment. The programme includes mindfulness practice, moderate-intensity aerobic activity such as stationary cycling or walking, resistance-band exercises, home practice, intervention videos, and adherence/safety monitoring through exercise logs and weekly reminders.
Enhanced Health EducationBehavioural
A Zoom-delivered attention-control programme including cancer self-management education, basic breath-awareness or relaxation, and light non-progressive physical activity guidance such as posture, gentle stretching, walking tips, and sit-to-stand activities.
| Study group | Role | What they receive |
|---|---|---|
| eMindExCare | Experimental | Participants will receive the 8-week eMindExCare intervention delivered via Zoom. The intervention integrates culturally adapted Cantonese mindfulness practices with home-based aerobic and resistance exercise. Sessions will be delivered once weekly for 8 consecutive weeks, with home practice at least three times per week. Participants will receive a stationary bike, resistance band, mindfulness mat and zafu set, intervention videos, exercise logs, and WhatsApp or WeChat reminders. Receives: Behavioral: eMindExCare |
| Enhanced Health Education | Active comparator | Participants will receive an 8-week enhanced health education attention-control programme delivered via Zoom. The programme will match the intervention group in contact time and engagement and will include cancer self-management education, basic breath-awareness or relaxation, and light non-progressive physical activity guidance. Participants will be encouraged to complete light relaxation or activity three times weekly and record this in a logbook. The programme will not include progressive aerobic training, resistance-band prescription, stationary bike provision, or a structured mindfulness curriculum. Receives: Behavioral: Enhanced Health Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recruitment feasibility measured by eligibility rate
Eligibility rate will be calculated as the number of eligible patients divided by the number of patients screened.
Measured: Through recruitment completion, up to 3 months
Recruitment feasibility measured by consent rate
Consent rate will be calculated as the number of eligible patients who provide informed consent divided by the number of eligible patients approached.
Measured: Through recruitment completion, up to 3 months
Randomization feasibility measured by randomization rate
Randomization rate will be calculated as the number of participants randomized divided by the number of participants who provide informed consent and complete baseline procedures
Measured: Through recruitment completion, up to 3 months
Intervention attendance rate
Attendance rate will be calculated as the proportion of scheduled intervention or control sessions attended by each participant.
Measured: Through completion of the 8-week intervention
Retention rate at post-intervention and follow-up
Retention rate will be calculated as the number of randomized participants who complete follow-up assessments divided by the number randomized.
Measured: Immediately after the 8-week intervention and 3 months after the intervention
Acceptability of outcome data collection measured by questionnaire completion rate
Questionnaire completion rate will be calculated for each assessment time point and each outcome measure
Measured: Baseline, immediately after the 8-week intervention, and 3 months after the intervention
Acceptability of outcome data collection measured by missing data rate
The proportion of missing data will be calculated for each questionnaire and assessment time point. The feasibility criterion is missing data of 20% or less.
Measured: Baseline, immediately after the 8-week intervention, and 3 months after the intervention
Secondary outcomes (8)
Subjective sleep quality
The Chinese Pittsburgh Sleep Quality Index includes 19 self-rated items across seven components. The global score ranges from 0 to 21, with higher scores indicating poorer sleep quality and scores of 5 or greater indicating clinically significant sleep disturbance.
Measured: Baseline, immediately after the 8-week intervention, and 3 months after the intervention
Objective sleep parameters
Wrist actigraphy will objectively assess sleep parameters over 7 consecutive days, including sleep efficiency, total sleep time, sleep onset latency, wake time after sleep onset, and awakenings.
Measured: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Physical activity
Wrist actigraphy will assess time spent in sedentary, light-intensity, moderate-intensity, vigorous-intensity, and very-vigorous-intensity activities. Data will be processed using ActiLife software and established cut-points.
Measured: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Fatigue
The Chinese Brief Fatigue Inventory includes items assessing fatigue severity and fatigue interference using 0 to 10 numeric rating scales. Higher scores indicate more severe fatigue or greater interference.
Measured: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Level of pain
The Chinese Brief Pain Inventory-Short Form assesses pain severity and pain interference using 0 to 10 numeric rating scales. Higher scores indicate greater pain severity or interference
Measured: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Quality of well-being
The Chinese Functional Assessment of Cancer Therapy-Prostate includes 39 items covering physical, social, emotional, functional, and prostate cancer-specific well-being. Total scores range from 0 to 156, with higher scores indicating better quality of life.
Measured: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Change in mindfulness
The Chinese Five Facet Mindfulness Questionnaire-15 includes 15 items rated on a 5-point Likert scale and assesses observing, describing, acting with awareness, non-judging, and non-reacting.
Measured: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Change in exercise motivation
The Chinese Behavioural Regulation in Exercise Questionnaire-2 includes 18 items across amotivation, external regulation, introjected regulation, identified regulation, and intrinsic regulation.
Measured: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jul 2026
- Study start1 Oct 2026 (estimated)
- Primary completion30 May 2028 (estimated)
- Study completion30 Sep 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Prostate CancerStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Single-blind, parallel, two-arm feasibility randomized controlled trial comparing eMindExCare with an enhanced health education attention-control programme.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Collaborators
- Chinese University of Hong Kong
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07735273
- Sponsor's protocol ID
- 23241311
- Acronym
- eMindExCare
- Status last verified
- Jan 2026
- First submitted
- 22 Jun 2026
- Last updated
- 29 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified participant-level data underlying published results may be made available upon reasonable request to the principal investigator, subject to ethics approval, institutional policy, and a data sharing agreement.
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Integrated Mindfulness and Exercise eHealth Intervention (eMindExCare) on Sleep, Fatigue, and Physical Activity Among Prostate Cancer Patients Undergoing Active Treatment: A Feasibility Trial
- ClinicalTrials.gov ID
- NCT07735273
- Acronym / sponsor ID
- eMindExCare / 23241311
- Conditions
- Prostate Cancer, Sleep Disturbance, Fatigue, Physical Inactivity, Pain
- Keywords
- Prostate Cancer, prostate neoplasms, eMindExCare, mindfulness, exercise, physical activity, eHealth, sleep quality
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Collaborators
- Chinese University of Hong Kong
- Study start
- 1 Oct 2026 (estimated)
- Primary completion
- 30 May 2028 (estimated)
- Study completion
- 30 Sep 2028 (estimated)
- First posted
- 29 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This feasibility randomized controlled trial will assess the acceptability, feasibility, and preliminary effects of an integrated mindfulness and exercise eHealth intervention, eMindExCare, among prostate cancer patients undergoing active treatment in Hong Kong. Participants will be randomized in a 1:1 ratio to either an 8-week eMindExCare intervention or an enhanced health education attention-control programme. eMindExCare integrates culturally adapted Cantonese mindfulness practices with home-based aerobic and resistance exercise delivered through Zoom, supported by home practice, exercise logs, and weekly reminders. The enhanced health education control programme will match the intervention group in contact time and engagement but will not include progressive aerobic training, resistance-band prescription, stationary bike provision, or a structured mindfulness curriculum. Feasibility and acceptability outcomes will include eligibility, consent, randomization, attendance, retention, questionnaire completion, missing data, and adverse events. Preliminary outcomes will include sleep quality, fatigue, pain, physical activity, mindfulness, motivation for exercise, and quality of life assessed at baseline, immediately post-intervention at week 8, and 3 months post-intervention.
Detailed description
Prostate cancer patients undergoing active treatment commonly experience interrelated symptoms, including sleep disturbance, fatigue, pain, and reduced physical activity. These symptoms may negatively affect physical functioning, psychological well-being, and quality of life. Mindfulness-based approaches may improve sleep quality and coping, while aerobic and resistance exercise may reduce fatigue, pain, and physical inactivity. However, these approaches are often delivered separately, and there is limited evidence on integrated mindfulness and exercise eHealth interventions for men with prostate cancer.
The eMindExCare programme was developed based on mindfulness-based cancer recovery principles, exercise and cancer guidelines, previous literature, and the study team's systematic reviews of exercise and mindfulness interventions. The programme is informed by the mindful coping model and self-determination theory. It aims to promote adaptive coping, present-moment awareness, intrinsic motivation for health behaviour change, and competence in practicing mindfulness and physical activity.
eMindExCare will be delivered online through Zoom over 8 consecutive weeks. Each weekly session will last approximately 60 minutes and will include a brief introduction, mindfulness practice, aerobic/resistance exercise, and sharing or discussion. The first session will be delivered in small groups of three to four participants to introduce the programme and explain how mindfulness and exercise may help manage cancer-related symptoms. The remaining sessions will be delivered individually, with follow-up and reminders through WhatsApp or WeChat. Participants will be encouraged to complete home-based practice at least three times per week for approximately 30 minutes. Intervention participants will be provided with a stationary bike, resistance band, mindfulness mat and zafu set, and mindfulness and exercise videos to support home practice.
Exercise will be delivered at a low-to-moderate intensity, approximately Borg Rating of Perceived Exertion 11-13, or a level at which participants can talk but not sing. Exercise intensity will be gradually progressed. Aerobic exercise will include stationary cycling or walking, and resistance training will use elastic bands to work major muscle groups. Participants will record daily practice and homework in a standardized exercise log.
Participants in the control group will receive an enhanced health education attention-control programme delivered via Zoom. The programme will include cancer self-management education, basic breath-awareness or relaxation, and light non-progressive physical activity guidance such as posture, gentle stretching, walking tips, and sit-to-stand activities. It will match the intervention group in contact time and engagement but will not include the structured eMindExCare mindfulness curriculum or progressive aerobic/resistance exercise prescription.
The primary objective is to assess the feasibility and acceptability of implementing eMindExCare in prostate cancer patients undergoing active treatment in the Hong Kong context. The secondary objective is to estimate preliminary effects on sleep quality, fatigue, pain, physical activity, mindfulness, exercise motivation, and quality of life. A process evaluation using semi-structured interviews will explore participants' experiences, perceptions, and feedback to refine the programme before a larger randomized controlled trial.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Single-blind, parallel, two-arm feasibility randomized controlled trial comparing eMindExCare with an enhanced health education attention-control programme.
| Arm | Type | Receives |
|---|---|---|
| eMindExCare | Experimental | Behavioral: eMindExCareParticipants will receive the 8-week eMindExCare intervention delivered via Zoom. The intervention integrates culturally adapted Cantonese mindfulness practices with home-based aerobic and resistance exercise. Sessions will be delivered once weekly for 8 consecutive weeks, with home practice at least three times per week. Participants will receive a stationary bike, resistance band, mindfulness mat and zafu set, intervention videos, exercise logs, and WhatsApp or WeChat reminders. |
| Enhanced Health Education | Active comparator | Behavioral: Enhanced Health EducationParticipants will receive an 8-week enhanced health education attention-control programme delivered via Zoom. The programme will match the intervention group in contact time and engagement and will include cancer self-management education, basic breath-awareness or relaxation, and light non-progressive physical activity guidance. Participants will be encouraged to complete light relaxation or activity three times weekly and record this in a logbook. The programme will not include progressive aerobic training, resistance-band prescription, stationary bike provision, or a structured mindfulness curriculum. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Diagnosed with prostate cancer, stage I, II, or III.
- Aged older than 18 years.
- Undergoing active treatment, including chemotherapy, radiotherapy, or hormone therapy, at Prince of Wales Hospital.
- Able to communicate and read Chinese.
- Has access to the Internet and a computer or tablet.
Key exclusion criteria (5 listed)
- Diagnosed with more than one primary cancer.
- Has metastatic disease.
- Has participated in a mindfulness programme.
- Is sufficiently physically active at the time of recruitment.
- Has a mental condition, World Health Organization/Eastern Cooperative Oncology Group performance status greater than 2, a physical disability that prevents participation in the intervention, or any other health problem that rules out regular physical activity as determined by the treating physician.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| eMindExCareAn integrated mindfulness and exercise eHealth intervention for prostate cancer patients undergoing active treatment. The programme includes mindfulness practice, moderate-intensity aerobic activity such as stationary cycling or walking, resistance-band exercises, home practice, intervention videos, and adherence/safety monitoring through exercise logs and weekly reminders. | Behavioural | eMindExCare |
| Enhanced Health EducationA Zoom-delivered attention-control programme including cancer self-management education, basic breath-awareness or relaxation, and light non-progressive physical activity guidance such as posture, gentle stretching, walking tips, and sit-to-stand activities. | Behavioural | Enhanced Health Education |
Primary outcome
Recruitment feasibility measured by eligibility rate
Time frame: Through recruitment completion, up to 3 months
Eligibility rate will be calculated as the number of eligible patients divided by the number of patients screened.
Recruitment feasibility measured by consent rate
Time frame: Through recruitment completion, up to 3 months
Consent rate will be calculated as the number of eligible patients who provide informed consent divided by the number of eligible patients approached.
Randomization feasibility measured by randomization rate
Time frame: Through recruitment completion, up to 3 months
Randomization rate will be calculated as the number of participants randomized divided by the number of participants who provide informed consent and complete baseline procedures
Intervention attendance rate
Time frame: Through completion of the 8-week intervention
Attendance rate will be calculated as the proportion of scheduled intervention or control sessions attended by each participant.
Retention rate at post-intervention and follow-up
Time frame: Immediately after the 8-week intervention and 3 months after the intervention
Retention rate will be calculated as the number of randomized participants who complete follow-up assessments divided by the number randomized.
Acceptability of outcome data collection measured by questionnaire completion rate
Time frame: Baseline, immediately after the 8-week intervention, and 3 months after the intervention
Questionnaire completion rate will be calculated for each assessment time point and each outcome measure
Acceptability of outcome data collection measured by missing data rate
Time frame: Baseline, immediately after the 8-week intervention, and 3 months after the intervention
The proportion of missing data will be calculated for each questionnaire and assessment time point. The feasibility criterion is missing data of 20% or less.
8 secondary outcomes
Subjective sleep quality
Time frame: Baseline, immediately after the 8-week intervention, and 3 months after the intervention
Objective sleep parameters
Time frame: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Physical activity
Time frame: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Fatigue
Time frame: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Level of pain
Time frame: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Quality of well-being
Time frame: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Change in mindfulness
Time frame: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Change in exercise motivation
Time frame: Seven consecutive days at baseline, immediately after the 8-week intervention, and 3 months after the intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2026.
- Individual participant dataSharing planned: Yes. De-identified participant-level data underlying published results may be made available upon reasonable request to the principal investigator, subject to ethics approval, institutional policy, and a data sharing agreement.
Related trials for Prostate Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Active, not recruitingObservational study
MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy
Prostate Cancer
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Prostate Cancer, Urinary Incontinence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing eMindExCare and Enhanced Health Education in people with Prostate Cancer and Sleep Disturbance, run by The University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hammoda ABU-ODAH, Assistanr Professor (+85294983446, hammoda@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recruitment feasibility measured by eligibility rate (time frame: Through recruitment completion, up to 3 months). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2026.